美国血液分离学会第九版血液分离指南更新要点  

Updated points of the American Society for Apheresis:The Ninth Special Issue Guidelines for Therapeutic Apheresis

作　　者：黄育敏 邬步云 HUANG Yu-min;WU Bu-yun(Department of Nephrology,The First Affiliated Hospital of Nanjing Medical University(Jiangsu Province Hospital),Nanjing 210029,China)

机构地区：[1]南京医科大学第一附属医院(江苏省人民医院)肾内科,南京210029

出　　处：《中国血液净化》2023年第9期644-648,共5页Chinese Journal of Blood Purification

摘　　要：治疗性血液分离是针对血液不同成分的不同性质,采用血液分离技术对血液成分进行分离,可作为清除体内毒素、抗体等物质的非药物性治疗方法。美国血液分离学会第九版指南较第八版新增了7条新的疾病指征、9条疾病新适应证,并改变8条旧适应证的证据等级。本文对该指南的更新进行简要综述。Therapeutic apheresis separates different blood components using blood separation techniques,which is a non-pharmacological treatment to remove toxins,antibodies and other substances from the body.In the ninth edition of American Society for Apheresis Guidelines,seven new disease indications,nine new indications for diseases,and changes of evidence level of eight older indications have been added compared to the eighth edition.This article provides a brief review of the updated guidelines.

关 键 词：治疗性血液分离 血浆置换 指南 进展 

分 类 号：R459.5[医药卫生—治疗学]